RxDoctor Payments Data

William Barnes, MD

General Practice · Salem, KYNPI 1215985148

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Endogastric Solutions, Inc at 53.3% of the total. Reporting peaked in 2023 at $1,748 and has fallen 83.2% since, to $293 in 2025. Among general practice clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,378in general payments, 2019–2025

Across 85 payments — averaging $63.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endogastric Solutions, Inc$3K
  • Apollo Endosurgery US Inc$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$414
  • Johnson & Johnson$170
  • Medtronic$158
  • Olympus America Inc.$133
  • plus $361 from 12 others

What the payments were for

  • Consulting fees$1,00019%
  • Travel & lodging$1,79633%
  • Food & beverage$2,58248%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,378 in reported general payments places this provider in the 95th percentile of 1,155 general practice providers in Kentucky.

See all general practice providers in Kentucky

Medicare billing

Part B allowed, 2024
$126,077
Medicare patients
191
Services billed
897

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$22,608
Buprenorphine32$10,741
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$1,968
Colestipol Hcl17$1,450
Sucralfate38$1,297
Enoxaparin Sodium14$1,214
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen85$951
Pantoprazole Sodium101$870
Fluconazole37$670
Famotidine46$385
Oxycodone Hcl20$356
Nitroglycerin PatchNitroglycerin15$292
Metoclopramide Hcl28$288
Metoprolol Succinate24$241
Diclofenac Sodium13$237

Paid to pharmacies, not to this prescriber.

Other general practice in Salem

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →